We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Diagnostics

Image: The workflow seamlessly integrates the KingFisher Flex platform with the BioCode MDx-3000 system to expand panel utility and increase respiratory testing throughput (Photo courtesy of Thermo Fisher Scientific)

Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

Applied BioCode’s BioCode Respiratory Pathogen Panel (RPP) has received FDA clearance for IVD use when paired with nucleic acid extraction on the Thermo Fisher Scientific's KingFisher Flex platform. More...
07 May 2026
Image: Overall workflow of the study. Targeted genes are ITGAM, PECAM1, CCL5, STAT1, STAT2, and CD44. (Dipanwita Nath et al, Cancer Medicine (2026). DOI: 10.1002/cam4.71775)

Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

New data reveal shared inflammatory genes linking pancreatic cancer with obesity/diabetes, enabling better risk stratification. More...
07 May 2026
Image: Blood RNA markers show potential for detecting HIV and tuberculosis complications and tracking treatment response in inflammatory bowel disease (Photo courtesy of Shutterstock)

Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response

An AI approach to whole-blood RNA forecasts disease course and therapy response from one sample to aid triage. More...
07 May 2026
Image: The findings provide the first evidence that pre-treatment epigenetic signals in cfDNA can distinguish semaglutide responders from non-responders, with important implications for the future of precision medicine in GLP-1 therapy (Photo credit: Adobe Stock)

Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

A new blood-based cfDNA methylation test and AI platform predicts semaglutide responders pre-treatment. More...
07 May 2026
Image: The findings support tumor genomic testing in pituitary carcinomas and aggressive pituitary adenomas, to guide consideration of immunotherapy as a potential first-line option (photo courtesy of Adobe Stock)

Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors

DNA testing for mismatch repair alterations guides immunotherapy, enabling complete responses in aggressive pituitary tumors. More...
05 May 2026
Image: Usability assessment (Yerlikaya S, Chirwa M, Ajide B, et al.; New England Journal of Medicine (2026). DOI: 10.1056/NEJMoa2509761)

Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care

A new tongue swab-based molecular test enables <35 min TB detection with 80% sensitivity and 99.5% specificity. More...
05 May 2026
Image: The minimally invasive, cost-effective liquid biopsy offers an accessible alternative to tissue biopsy for tailoring breast cancer treatment strategies (photo credit: 123RF)

Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer

A new liquid biopsy transcriptome assay predicts pembrolizumab response and neoadjuvant outcomes in HER2-negative breast cancer. More...
05 May 2026
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
Prefilled Tubes
Prefilled 5.0ml Tubes


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.